INTRODUCTION
Influenza, in its zoonotic, seasonal epidemic and pandemic forms, causes a substantial impact on global public health. Every year, an estimated 500,000 deaths worldwide, both of very young children, but mostly older adults, are attributed to seasonal influenza virus infections (World Health Organization, 2009). The past 100 years have seen four influenza pandemics: H1N1 in 1918, H2N2 in 1957, H3N2 in 1962, and H1N1 in 2009 (Simonsen et al., 1998; Bautista et al., 2010) . With each pandemic came a spike in hospitalization and death rates in addition to a higher proportion of deaths in people under the age of 65, although the relative impact varied widely with the different viruses (Simonsen et al., 1998; Belongia et al., 2010) . On May 28, 2010 worldwide more than 214 countries and overseas territories or communities have reported laboratory confirmed cases of pandemic influenza H1N1 2009, including over 18,114 deaths (Belongia et al., 2010) .
Although pandemic and seasonal influenza usually cause self-limited illnesses, a small percentage of cases are fatal ). The findings in various studies suggest that severe disease is associated with the development of influenza viral pneumonia ( 
Biosynthesis of nitric oxide
In the respiratory tract, NO is produced by a wide variety of cell types, including epithelial cells, airway nerves, inflammatory cells (monocytes, macrophages, neutrophils, mast cells) and vascular endothelial cells (Ricciardolo, 2003; Barnes, Belvisi, 1993) . NO is synthesized from L-arginine in a reaction catalyzed by a family of nitric oxide synthase (NOS) enzymes. Conversion of L-arginine to NO and L-citrulline requires also nicotinamide adenine dinucleotide phosphate (NADPH) and oxygen (O 2 ) as co-substrates and tetrahydrobiopterin (BH 4 ), flavin adenine dinucleotide (FAD), flavin mononucleotide (FMN) and iron (heme) as cofactors (Ricciardolo, 2003; Hobbs, Ignarro, 1997) . The NOS is structurally divided into two major domains, the reductase and oxygenase domains (Ricciardolo, 2003; Marletta, 1993) . Calmodulin couples these domains and transfers electrons between flavins and the heme moiety (Ricciardolo, 2003 ; Abu-Soud, Stuehr, 1993).
The NOS exists in three distinct isoforms. Constitutive neural NOS (nNOS or NOS I) is predominantly expressed within neurons in brain and peripheral nervous system. Constitutive endothelial NOS (eNOS or NOS III) is mainly expressed in endothelial cells (Ricciardolo, 2003; Förstermann et al., 1991 
Regulation of inducible nitric oxide synthase expression
Human iNOS shares 80% homology to murine iNOS at the amino acid levels (Chartrain et al., 1994; Guo et al., 2006) , but translation of the results describing the mechanisms of mouse iNOS expression to that of human is not always straightforward. The size of the iNOS promoter differs greatly between mouse (~1.5 kb) and man (up to 16 kb) (Lowenstein et al., 1993) . Many mouse cells readily express iNOS in response to LPS or to a single cytokine, whereas human cells usually require a combination of different cytokines for detectable iNOS expression and NO synthesis (Korhonen et al., 2005) . Unlike rodent mononuclear phagocytes and granulocytes, both human macrophages and monocytes do not release significant amounts of NO in vitro when stimulated with the classical iNOS inducers -interferon-gamma (IFN-γ) and lipopolysaccharide, although in vivo NO production during inflammatory processes seems evident (Muijsers et al., 2001) . iNOS has been immunolocalized within the airway cells or human lung tissue that has been obtained from patients with acute respiratory distress syndrome, bacterial pneumonia, lung cancer, pulmonary sarcoi dosis, idiopathic pulmonary fibrosis and asthma (Sittipunt et Despite the differences noted above, similarities exist between murine and human iNOS genes in terms of activating factors and conditions. The viral replication or viral components, bacterial LPS and cytokines, such as interleukin 1β (IL-1β), tumor necrosis factor α (TNF-α), interferon α/β (IFN-α/β) and IFN-γ can stimulate expression of the iNOS gene in both mouse and human cells during infectious processes. These inducers mediate the activation of cellular transcription factors -nuclear factor κB (NF-κB), signal transducer The expression of iNOS is regulated at transcriptional and posttranscriptional levels (Turpeinen et al., 2011). LPS and IFN-γ induce mouse iNOS promoter activity 50-100-fold (Lowenstein et al., 1993) . Cytokine stimulation increases human iNOS promoter activity only approximately 7-to 10-fold, while mRNA expression increases more than 100-fold (Rodriguez-Pascual et al., 2000; De Vera et al., 1996) . This demonstrates important differences in transcriptional and posttranscriptional regulation of iNOS expression between mouse and human cells (Turpeinen et al., 2011) . Recent evidence supports the idea that regulation of iNOS mRNA stability is an important means to regulate iNOS expression. In the unstimulated macrophages and monocytes, nuclear run-on assays show continuous iNOS transcription, whereas human iNOS promoter constructs have basal activity (Korhonen et al., 2005) . However, no iNOS mRNA or protein can be detected within the unstimulated macrophages and monocytes, indicating the highly unstable nature of iNOS mRNA is highly unstable in these cells (Korhonen et al., 2005) .
Role of nitric oxide during infections: molecular mechanisms of action
During microbial infections, excessive NO produced by iNOS has diverse functions ranging from antimicrobial and antiinflammatory host defense and cytoprotection to proinflamatory and cytotoxic activities (Zaki et al., 2005) . The host defense function of NO is best characterized by antimicrobial and cytoprotective activities that have been observed in bacterial, fungal, and parasitic infections ONOO − not only damages host tissues and cells in a nonselective manner, it also affects biomolecules of a host in a relatively selective fashion. For example, ONOO − activates matrix metalloproteinases (MMPs) -the enzymes that participate in the destruction of the extracellular matrix, which leads to tissue damage and remodeling (Okamoto et al., 2001; 2004) . MMPs are also known to have a critical role in apoptosis induction (Okamoto et al., 2004) . ONOO − readily inactivates both tissue inhibitor of MMP and α1-proteinase inhibitor, which is a major proteinase inhibitor in human plasma (Moreno, Pryor, 1992; Frears et al., 1996) . ONOO − also activates cyclooxygenase -the key enzyme for production of potent inflammatory prostaglandins (Landino et al., 1996) . Thus, ONOO − produced during virus-induced inflammation may promote tissue injury in many ways.
Other important functions of ONOO − include the induction of apoptosis and necrosis, possibly via mitochondrial damage, which leads to cytochrome c release (Hortelano et al., 1999) .
During viral and other microbial infections, NO is produced by iNOS in macrophages and phagocytic cells as an innate host response to the infectious agent. Studies with murine models on the molecular mechanism of iNOS activation revealed that several cytokines, including IFN-γ, TNF-α, and IL-1, are responsible for this activation, with IFN-γ playing the pivotal role (Drapier et al., 1988; Xie et al., 1993) . IFN-γ is a cytokine of major importance for inducing iNOS and NO overproduction during viral infections (Zaki et al., 2005) .
Role of nitric oxide on influenza virus infection in mice
As an effector molecule produced by phagocytic cells, NO has antiviral activity that is associated with nonspecific damage of host cells and tissues worsening the clinical course of viral infections. Therefore, in spite of the antiviral activity, excessive production of NO may facilitate viral pathogenesis (Zaki et al., 2005) . This was demonstrated in a series of investigations on influenza virus infection in mice.
In 1996, Akaike et al. (1996) demonstrated that overproduction of NO in mouse lungs during influenza virus infection leads to the development of pneumonia. Both the enzymatic activity and mRNA expression of the iNOS were greatly increased in the mouse lungs, and it was mediated by IFN-γ. The time profile of iNOS induction in the lung correlated well with that of pulmonary consolidation rather than that of viral replication (iNOS expression began to increase on the 4th day after virus infection followed by rapid increment until 8 days after infection and diminished quickly thereafter). To establish the occurrence of NO overproduction directly in the mouse lung after infection with influenza virus, lung tissue was analyzed via ESR spectroscopy with a dithiocarbamate and iron complex as a spin trap for NO. Inhibition of NO by N ω -monomethyl-L-arginine (L-NMMA) treatment of the influenza virus-infected mice resulted in significant improvement of the survival rate. Immunohistochemistry with a specific anti-3-nitrotyrosine antibody showed intense staining of alveolar phagocytic cells, such as macrophages and neutrophils, and intraalveolar exudate in the virus-infected lung. 3-Nitrotyrosine formation as a consequence of peroxynitrite caused protein nitration thus indicating generation of peroxynitrite in the pathological process of influenza virus-induced pneumonia (Akaike et al., 1996) .
NO-mediated pathogenesis of viral pneumonia was further investigated using genetically deficient iNOS -/-mice. The results revealed that influenza virus infection of the wild-type (iNOS +/+ ) mice increased NO levels in the bronchoalveolar lavage fluid and led to high mortality apparently because of the associated consolidating pneumonitis with massive inflammatory foci and edema within the lungs. The mice lacking the iNOS gene survived with little histopathologic evidence of pneumonitis (Karupiah et al., 1998) . The enhanced antiviral antibody secretion and attenuated immunopathology during influenza virus infection was also reported in the study with iNOS-deficient mice (Jayasekera et al., 2006) . The data of this investigation suggest that an increased virus-specific antibody response, rather than an enhanced cytotoxic T-cell response, may account for the reduced susceptibility of iNOS -/-mice to influenza A virus infection. Previous studies have demonstrated that influenza A virus replication is sensitive to CD8+ T cell-mediated cytolysis, NKcell effector activity and the presence of virus-specific antibody (Bender et al., 1992 ; Mozdzanowska et al., 1997; Stein-Streilein, Guffee, 1986). Each of these components of the immune response during infection of iNOS -/-mice with a sublethal dose of virulent influenza A virus was examined in this study. Both influenza A virus specific CD8+ Tcell and NK-cell cytolytic activities were similar in iNOS -/-and iNOS +/+ mice. Thus, the T-cell and NK-cell cytotoxic responses do not contribute to the increased viral clearance in iNOS -/-mice. However, the virus-infected iNOS -/-mice produced higher levels of virus-specific IgG2a antibody. Furthermore, more viable B cells and plasmablasts, along with greater levels of IFN-γ, were found in iNOS -/-splenocyte cultures stimulated with B-cell mitogens. iNOS -/-mice demonstrated a delay in manifestation of clinical illness and developed a statistically lower clinical illness score from day 7 of infection compared with iNOS +/+ mice. Also, there was a significant attenuation in the extent of lung lesions in iNOS -/-mice. Inflammatory cell migration and proinflammatory cytokine production were attenuated significantly in the lungs of influenza A virus-infected iNOS -/-mice. Importantly, this correlated directly with lower clinical illness and lung lesions observed in iNOS -/-mice, suggesting that iNOS exacerbates viral pneumonia by contributing to the recruitment of inflammatory leucocytes and to the prolonged expression of proinflammatory cytokines (Jayasekera et al., 2006) .
In a recently performed study with mice, Aldridge et al. (2009) analyzed the new possibility for a new therapeutic intervention proposed for the case of a catastrophic pandemic. They showed that challenging mice with virulent influenza A viruses, including H5N1 strains, caused an increased selective accumulation of a particular dendritic cell subset, the TNF-α/iNOS-producing DCs (tipDC), in the pulmonary airways. However, although it might be expected that eliminating the tipDCs would ameliorate the disease process, the authors found the opposite phenomenon. The tipDCs also drive a local, protective CD8 + "killer" T cell response in the virus-infected respiratory tract. Most interestingly, this study established that partially compromising tipDC recruitment can be protective. Giving mice the peroxisome proliferator-activated receptor-γ agonist pioglitazone diminishes but does not prevent tipDC recruitment, while allowing for sufficient CD8 + T cell expansion to protect against an otherwise lethal or at least highly pathogenic influenza virus challenge (Aldridge et al., 2009) . It is noteworthy that not only influenza virus infection causes pulmonary pathology associa ted with iNOS. Other pneumotropic viral infections are also responsible for NO induced damage of lung tissues. A study with herpes simplex virus type 1 (HSV-1)-induced pneumonia in mice was performed (Adler et al., 1997) . Immunohistochemical staining demonstrated iNOS induction and the nitrotyrosine antigen in the lungs of infected, but not of uninfected mice, suggesting that NO contributes to the development of pneumonia. Infected mice treated with the NOS inhibitor, N G -monomethyl-1-arginine (1-NMMA), had less histological evidence of pneumonia, improved survival and pulmonary compliance of HSV-1 infected mice compared with those receiving placebo treatment, despite the presence of high pulmonary viral titers (Adler H et al., 1997) . Stark et al. (2005) examined the effect of respiratory syncytial virus (RSV) infection on expression of iNOS and the role of NO in the host responses to RSV in vivo. NO production, iNOS mRNA and protein levels were significantly increased in RSVinfected mice, and immunohistochemical analysis clearly identified iNOS in the respiratory epithelium. Suppression of NO synthesis using iNOS inhibitors increased RSV titers in the lungs, on the other hand, it reduced lung inflammation and RSV-induced airway hyper-responsiveness (Stark et al., 2005) . 6 intensive care unit patients with lethal A/H1N1 influenza viral pneumonia. The most predominant pathological findings were diffuse alveolar damage, accompanied by hemorrhage in all cases and necrotizing bronchiolitis. All cases showed increased tyrosine nitration in the immuno fluorescence studies, which indicates formation of peroxynitrite and subsequent protein nitration. The iNOS protein levels were increased in all cases. In addition, oxidized dihydroethidium staining, indicating the formation of oxygen free radicals, was increased in all cases. The increased oxidized dihydroethidium and nitrotyrosine reactivity were observed even in cases with prolonged ARDS, suggesting a role for prolonged oxidative and nitrative stress in the pathogenesis of ARDS in H1N1 influenza virus infection despite antiviral treatment. Other data from this study demonstrated viral proteins within macrophages and type I pneumocytes indicating they may remain in lung tissues for prolonged periods of time (Nin et al., 2012) and possibly participating in the prolongation of the inflammatory response.
Role of nitric oxide on influenza virus infection in humans
In another study, a detailed histopathological analysis of the open lung biopsy specimens from five patients with ARDS with confirmed H1N1 was performed (Capelozzi et al., 2010) . Lung specimens underwent microbiologic analysis and examination by optical and electron microscopy. Immunophenotyping was used to characterize macrophages, natural killer, T and B cells as well as the expression of cytokines and iNOS. Ultrastructural analysis showed viral-like particles in bronchiolar and alveolar epithelial cells in all cases. The main pathological findings revealed necrotizing bronchiolitis and diffuse alveolar damage; the altered respiratory epithelial cells probably served as the primary target of the infection. In these cases, expression in the lung of IFN-γ by small mononucleated cells and TNF-α by macrophages and alveolar epithelial cells was low. Conversely, a very strong expression of IL-4, IL-10 and iNOS by macropha ges was found. The results of this study indicate that in swine-origin influenza virus infection, altered innate and adaptive immune responses may lead to incomplete virus eradication in the primary target of the infection and, consequently, imbalance between inflammation and immune down-regulation resulting in bronchiolar obliteration and diffuse alveolar damage (Capelozzi et al., 2010) .
The nitrative stress during influenza infection may be evaluated not only by histopathological findings in the lungs, but also serologically. In 2011 Al-Nimer et al. (2011) evaluated the levels of NO and peroxynitrite in the serum of patients during seasonal and pandemic H1N1 infection. They found the greater levels of serum NO and peroxynitrite in patients infected with seasonal and pandemic H1N1 influenza as compared to the healthy control subjects. Although side-by-side comparisons may not be valid, it is interesting to note that the reported serum concentrations of reactive nitrogen species were higher in seasonal influenza patients than pandemic influenza patients.
CONCLUSIONS
Despite the differences between murine and human iNOS genes and their induction mechanisms, the evidence supports that infectious processes, including influenza, can trigger a nitrative stress in human lungs contributing to the pulmonary inflammation and tissue injury. More investigations need to be performed in order to extend our understanding on the role of reactive nitrogen oxides in inflammation and on the mechanisms that regulate iNOS expression, especially in human cells. This may offer new insights for the development of novel treatment of diseases complicated by increased iNOS expression and NO overproduction.
